| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| CLOCK |
liver |
|
Permissive
|
Mus musculus |
GSE53828
...
|
MA0819.1
|
| CLOCK |
liver |
|
Permissive
|
Mus musculus |
GSE53828
...
|
MA0819.1
|
| CLOCK |
Beta-TC-6 (insulinoma) |
|
Permissive
Robust
|
Mus musculus |
GSE70960
...
|
MA0819.1
|
| CREB1 |
bone marrow-derived macrophages |
lipid A 0 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
| CREB1 |
bone marrow-derived macrophages |
lipid A 15 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
| CREB1 |
bone marrow-derived macrophages |
lipid A 30 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
| CREB1 |
bone marrow-derived macrophages |
lipid A 60 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
| CREB1 |
bone marrow-derived macrophages |
lipid A 120 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0018.4
|
| CREB1 |
MDA-MB-134 (invasive lobular breast carcinoma) |
Treatment:a cocktail of 10 µM forskolin plus 100 µM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line |
Permissive
Robust
|
Homo sapiens |
GSE109103
...
|
MA0018.4
|
| CREB1 |
Ishikawa (endometrial adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BUR
|
MA0018.4
|
Showing 10 records in page 32
from 358 pages